Insmed
INSM
#1116
Rank
ยฃ16.05 B
Marketcap
ยฃ74.07
Share price
3.07%
Change (1 day)
-0.89%
Change (1 year)

Insmed (INSM) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : ยฃ1.03 Billion

According to Insmed's latest financial reports the company's total liabilities are ยฃ1.03 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Insmed - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31ยฃ1.13 B-18.29%
2024-12-31ยฃ1.38 B6.29%
2023-12-31ยฃ1.30 B0.61%
2022-12-31ยฃ1.29 B110.08%
2021-12-31ยฃ0.61 B61.69%
2020-12-31ยฃ0.38 B4.14%
2019-12-31ยฃ0.36 B17.4%
2018-12-31ยฃ0.31 B317.81%
2017-12-31ยฃ74.72 M10.46%
2016-12-31ยฃ67.64 M123.49%
2015-12-31ยฃ30.27 M5.6%
2014-12-31ยฃ28.66 M42.53%
2013-12-31ยฃ20.11 M-0.53%
2012-12-31ยฃ20.21 M464.6%
2011-12-31ยฃ3.58 M61.55%
2010-12-31ยฃ2.21 M28.99%
2009-12-31ยฃ1.71 M-66.78%
2008-12-31ยฃ5.17 M28.26%
2007-12-31ยฃ4.03 M-45.4%
2006-12-31ยฃ7.38 M3.21%
2005-12-31ยฃ7.15 M137.86%
2004-12-31ยฃ3 M49.83%
2003-12-31ยฃ2 M-33.75%
2002-12-31ยฃ3.03 M-63.1%
2001-12-31ยฃ8.21 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
ยฃ59.89 B 5,706.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
ยฃ24.71 B 2,295.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ5.35 B 419.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
ยฃ1.25 B 22.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
ยฃ0.40 B-60.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
ยฃ0.90 B-11.95%๐Ÿ‡บ๐Ÿ‡ธ USA